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Apoptotic death of T lymphocytes is critical for shut-
down of immune responses and hemopoietic cell ho-
meostasis. Both death receptor (Fas) activation and
mitochondrial apoptosis triggered by the BH3-only
protein Bim have been implicated in the killing of anti-
gen-stimulated T cells. We examinedmice lacking the
gene encoding Bim (Bcl2l11) and with the inactivating
lpr mutation in the gene encoding Fas (Fas), desig-
nated Bcl2l11/Faslpr/lprmice. Shutdown of an acute
T cell response to herpes simplex virus involved
only Bim with no contribution by Fas, whereas both
pathways synergized in killing antigen-stimulated
T cells in chronic infection with murine g-herpesvirus.
Bcl2l11/Faslpr/lpr mice developed remarkably en-
hanced and accelerated fatal lymphadenopathy and
autoimmunity compared to mice lacking only one of
these apoptosis inducers. These results identify criti-
cal overlapping roles for Fas and Bim in T cell death
in immune response shutdown and prevention of im-
munopathology and thereby resolve a long-standing
controversy.
INTRODUCTION
In response to infection or immunization, T cells that express
antigen-specific T cell receptors (TCR) become activated and
proliferate, and some differentiate into effector cells (Sprent
and Tough, 2001). Activated T cells then produce cytokines that
help coordinate the immune response aimed at eliminating the
pathogen. Clearance of the antigen is accompanied by the shut-
down of T cell immune responses and involves apoptosis of
a large fraction of antigen-activated T cells. This prevents accu-
mulation of no-longer-needed and potentially dangerous effector
cells and thereby precludes immunopathology. Two distinct
but ultimately converging pathways control apoptosis initiation
in mammalian cells (Strasser et al., 1995). Ligation of ‘‘death re-
ceptors,’’ members of the tumor necrosis factor receptor (TNF-
R) family with an intracellular ‘‘death domain’’ (e.g., Fas or the
tumor necrosis factor receptor 1 [TNF-R1]) triggers formationof the ‘‘death-inducing signaling complex’’ (DISC), which pro-
motes cell demolition through activation of caspase-8 (Ashkenazi
and Dixit, 1998; Krammer, 2000; Wallach et al., 1998). Con-
versely, the ‘‘mitochondrial’’ (also called ‘‘intrinsic’’ or ‘‘B cell
lymphoma [Bcl-2]-regulated’’) apoptotic pathway, activated by
developmental cues or cytotoxic stimuli, such as cytokine depri-
vation, is independent of caspase-8 and Fas-associated death
domain protein (FADD), but instead involves mitochondrial re-
lease of cytochrome c, which promotes Apaf-1-mediated activa-
tion of caspase-9 (Green and Kroemer, 2004; Wang, 2001). This
pathway is controlled by the Bcl-2 protein family, which consists
of three subgroups: the Bcl-2-like prosurvival proteins essential
for cell survival; the Bax and Bak-like proteins required for mito-
chondrial outer membrane disruption, release of apoptogenic
proteins (e.g., cytochrome c), and activation of the caspase cas-
cade (Green and Kroemer, 2004; Wang, 2001); and the proteins
containing only the Bcl-2 homology domain 3 (BH3-only pro-
teins, e.g., Bim), which are activated by distinct death stimuli
and are essential for initiation of apoptosis signaling (Huang
and Strasser, 2000).
Both death receptor signaling and themitochondrial apoptotic
pathway have been shown to be critical for lymphocyte homeo-
stasis (Krammer, 2000; Sprent and Tough, 2001). Mice (Wata-
nabe-Fukunaga et al., 1992) or humans (ALPS, autoimmune lym-
phoproliferation syndrome patients) (Rieux-Laucat et al., 1995)
defective for Fas (Faslpr/lpr mice) or its ligand, FasL (Faslgld/gld
mice), develop progressive lymphadenopathy and splenomeg-
aly resulting from accumulation of excess mature T and B cells
as well as ‘‘unusual’’ abTCR+CD4CD8B220+ T cells. Bcl-2-
deficient mice (Veis et al., 1993) and mice lacking myeloid cell
leukemia 1 (Mcl-1) in the hematopoietic system (Opferman
et al., 2005) exhibit profound lymphopenia, whereas mice over-
expressing a Bcl-2 transgene throughout the hematopoietic
compartment show marked lymphadenopathy (Ogilvy et al.,
1999). Mice lacking the BH3-only protein Bim also accumulate
excess lymphocytes andmyeloid cells and these cells are abnor-
mally resistant to cytokine deprivation, deregulated calcium flux,
and ER stress (Bouillet et al., 1999; Puthalakath et al., 2007).
Moreover, Bim is critical for apoptosis during negative selection
of autoreactive thymocytes (Bouillet et al., 2002), mature T cells
(Davey et al., 2002), and B cells (Enders et al., 2003).
The relative contributions of the two distinct apoptotic path-
ways in the termination of T cell immune responses has been
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Bim and Fas Cooperate in Chronic Immune Responsesa matter of controversy for a long time. FasL and Fas have been
implicated because activation-induced cell death (AICD), an
in vitro model in which mitogen-activated T cell blasts are killed
by TCR restimulation, which causes FasL upregulation, is in-
hibited by FasL or Fas inactivation (Brunner et al., 1995; Dhein
et al., 1995; Russell et al., 1993). Moreover, clearance of Staph-
ylococcus Enterotoxin B (SEB)-activated TCR Vb8+ T cells was
reported to depend partially on Fas (Mogil et al., 1995; Van Parijs
et al., 1996). The mitochondrial pathway has been implicated in
immune response shutdown, because Bcl-2 overexpression
(Strasser et al., 1991), loss of Bim (Hildeman et al., 2002; Pelle-
grini et al., 2003), or Bax and Bak deficiency (Rathmell et al.,
2002) inhibited death of T cells stimulated in vitro or in vivo by
a single dose of SEB or in vivo after infection with human herpes
simplex virus (HSV-1). It is conceivable that Fas and Bim may
have overlapping roles in T cell killing, with their relative contribu-
tion determined by the nature of the immune response (acute
versus chronic). In acute immune responses, apoptosis is trig-
gered by the drop in cytokine amounts, after clearance of the
pathogen or injected immunogen (Hildeman et al., 2002; Kram-
mer, 2000; Sprent and Tough, 2001). A single administration of
SEB, which is known to be eliminated quickly from the body
(Vabulas et al., 1996), would therefore mimic an acute infection.
In contrast, TCR restimulation of activated T cells in vitro (AICD)
or repeated administration of SEB tomice ismore likely to imitate
the repeated TCR activation that is thought to occur during
chronic immune responses, such as persistent infections or
stimulation with self-antigens (Krammer, 2000; Sprent and
Tough, 2001).
The removal of effector T lymphocytes prevents immunopa-
thology, but the mechanisms for apoptosis induction remain
contentious (Krammer, 2000; Sprent and Tough, 2001). In the
present study, we have generated mice lacking Bim and harbor-
ing the inactivating lpr mutation in the Fas gene, and we used
acute and chronic viral infection models to decipher the indi-
vidual and combined roles of Fas and Bim in the shutdown of
T cell immune responses and in immunopathology.
RESULTS
Bcl2l11/Faslpr/lpr Lymphoid Cells Are Resistant
to Both Fas-Transduced as well as Bim-Dependent
Apoptotic Stimuli
To investigate the functional interaction of Bim and Fas in the
control of lymphocyte homeostasis, we generated mice lacking
both of these apoptosis inducers (with both parental strains
backcrossed to C57BL/6 >20 generations prior to intercrossing).
Bim is required for the killing of lymphocytes induced by growth
factor withdrawal, deregulated calcium flux, DNA damage, or
treatment with dexamethasone (Bouillet et al., 1999). Bcl2l11/
thymocytes are, however, normally sensitive to treatment with
phorbol myristyl acetate (PMA, a death stimulus that can be
countered by Bcl-2 overexpression) or FasL, which triggers the
death receptor pathway (Bouillet et al., 1999). To determine the
consequences of the combined mutations on cell survival, we
sorted several lymphocyte populations and subjected them in
culture to cytokine deprivation, treatment with FasL, the calcium
ionophore ionomycin, PMA, or the DNA damage-inducing drug
etoposide. CD4+CD8+ thymocytes (Figure 1A) as well as mature
198 Immunity 28, 197–205, February 2008 ª2008 Elsevier Inc.B cells (see Figures S1E–S1G available online) and T cells (CD4+,
CD8+, and abTCR+CD4CD8B220+; Figures 1B and 1C;
Figure S1) from Bcl2l11/Faslpr/lpr mice were resistant to both
FasL as well as Bim-dependent apoptotic stimuli, such as
growth factor withdrawal or treatment with ionomycin. Thymo-
cytes remained, however, normally sensitive to PMA (Figure 1),
which was shown to require the BH3-only protein Puma for cell
killing (Villunger et al., 2003). These results demonstrate that
Fas signaling and Bim exert nonredundant roles in the apo-
ptosis of hemopoietic cells.
Clearance of HSV-Specific CD8+ T Cells in Acute
Infection Requires the BH3-Only Protein Bim
but Is Fas Independent
Although the importance of Fas and Bim in lymphocyte homeo-
stasis is widely accepted, their respective roles in immune re-
sponse shutdown remain controversial (Hildeman et al., 2002;
Krammer, 2000; Sprent and Tough, 2001). We addressed the ex-
isting controversy by measuring the numbers of antigen-stimu-
lated CD8+ T cells in spleen and lymph nodes during acute and
chronic immune responses in Bcl2l11/Faslpr/lpr as well as
Bcl2l11+/Faslpr/lpr, Faslpr/lpr, Bcl2l11/, and WT mice (Figures
2A–2D and 3A–3D). Consistent with the acute nature of an
HSV-1 (HSV1 KOS) infection and the ensuing immune response
(Pellegrini et al., 2003), all micewere able to clear the virus rapidly
(not shown). Previous studies have shown that the number of
HSV-specific CD8+ T cells in the spleen of WT and Faslpr/lpr
mice peaks at day 7, after which the majority of these effectors
are eliminated by cell death (Pellegrini et al., 2003). Consistent
with this, flow cytometric analysis showed that the spleens of
WT and Faslpr/lpr mice contained only low numbers (<106) of
HSV-specific CD8+ T cells on days 17 and 35 after HSV infection
(Figures 2A and 2B). In contrast, inBcl2l11/mice, the numbers
of HSV-specific CD8+ T cells in the spleen did not fall substan-
tially after pathogen clearance (Figure 2E). Notably, the addi-
tional loss of Fas (in Bcl2l11/Faslpr/lpr mice) did not further
increase the accumulation of viral antigen-stimulated CD8+ T
cells (Figure 2E). HSV-specific CD8+ cell numbers were also sim-
ilar in nonlymphoid tissues (lungs and liver) of Bcl2l11/ and
Bcl2l11/Faslpr/lpr mice 17 and 35 days after infection with
HSV-1 (Figure S2). These results demonstrate that Fas activa-
tion, which requires repeated TCR stimulation to upregulate
FasL in T cells, is not involved in the shutdown of acute immune
responses; instead, this death ismediatedpredominantly byBim.
Bim and Fas Cooperate to Eliminate MHV-OVA-Specific
T Cells in Chronic Infection
Bothmitochondrial aswell as Fas-mediated apoptosis havebeen
hypothesized to mediate the death of CD4+ as well as CD8+ T
cells during chronic antigenic stimulation (Krammer, 2000;
Sprent and Tough, 2001). We therefore examined the individual
and combined roles of BimandFas in the T cell immune response
to mouse g-herpes virus (MHV) transgenically expresssing
ovalbumin (MHV 68-OVA) (Figure 3). This virus causes a chronic
infectionpredominantly in the lungandBcells,with persistent an-
tigen presentation in the lung (Figure S3; Rajcani and Kudelova,
2005). Total numbers of leukocytes as well as CD8+ T cells
were determined 14, 40, and 60 days after infection (Figures
3A–3D). Surface staining for viral antigen (ovalbumin)-specific
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Bim and Fas Cooperate in Chronic Immune ResponsesFigure 1. Leukocytes from Bcl2l11/Faslpr/lprMice Are Resistant to
Both FasL as well as to Bim-Dependent Apoptotic Stimuli
(A) CD4+8+ thymocytes from mice of the genotypes indicated were purified by
FACS after staining with antibodies to CD4 and CD8. Cells were challenged inTCR (Figures 3E and 3F) or intracellular staining for IFN-g
production after brief antigenic (ovalbumin) stimulation in culture
(Figures 3G and 3H) demonstrated that in spleens and draining
lymph nodes of WT mice, MHV-OVA-specific CD8+ T cells
(undetectable prior to infection) were greatly expanded on
days 14 and 40 after infection, followed by a loss of nearly
50%of these cells by day 60. Loss of Bim resulted in a significant
(p < 0.05), albeit relatively small, increase in MHV-OVA-specific
CD8+ T cells on days 40 and 60, which was particularly promi-
nent in the spleen (Figures 3E and 3G). Fas-deficient mice con-
tained similarly increased numbers of these cells (Figures 3E
and 3G; p < 0.05). Remarkably, the combined absence of both
apoptosis inducers had dramatic effects, causing a 43- or 63-
fold increase of MHV-OVA-specific CD8+ T cells in the spleen
compared to WT mice on days 40 and 60, respectively. The
increase of MHV-OVA-specific CD8+ T cells in the mediastinal
lymph nodes was even more spectacular, with an 83- or 845-
fold difference compared to WT mice observed on days 40
and 60, respectively (Figures 3F and 3H). This preferential
increase of antigen-specific CD8+ T cells in the draining lymph
nodes might be a consequence of the ongoing antigen release
from the lungs resulting in lymphocyte homing to this site. These
results demonstrate that Fas-mediated death receptor signaling
and the Bim-mediated mitochondrial apoptotic pathway co-
operate to prevent deregulated expansion of activated T cells
during chronic antigenic stimulation.
Bcl2l11/Faslpr/lpr andBcl2l11+/Faslpr/lprMiceDevelop
Extreme Lymphadenopathy
Loss of either Bim or Fas both lead tomarked lymphadenopathy.
Whereas Bcl2l11/ mice show an increase in most lymphoid
and myeloid cell populations in the periphery (Bouillet et al.,
1999), lymphadenopathy in Faslpr/lpr mice is due in large part to
the accumulation of unusual abTCR+CD4CD8B220+ T cells
(Watanabe-Fukunaga et al., 1992). These unusual T cells are
not found in WT or Bcl2l11/ mice. Bcl2l11/Faslpr/lpr and
even Bcl2l11+/Faslpr/lpr mice developed lymphadenopathy
and splenomegaly at a dramatically increased magnitude and
rate compared to mice lacking either apoptosis initiator alone
(Figure 4; Figure S5). In particular, the abTCR+CD4CD8B220+
T cell population was increased 4–5 times in the spleen of
Bcl2l11/Faslpr/lpr mice compared to Faslpr/lpr mice. Precise
quantification in the lymph nodes was made impossible by
huge variations between individual mice (one particular
Bcl2l11/Faslpr/lprmousewas found to have 12.7 g of lymph no-
des; Figure S6), but very large lymph nodes were a hallmark of all
Bcl2l11/Faslpr/lpr and Bcl2l11+/Faslpr/lpr mice (Figures S5A
and S5B). Conventional CD4+ and CD8+ T cells, B cells, and, un-
expectedly, granulocytes were alsomarkedly increased in spleens
and lymph nodes of Bcl2l11/Faslpr/lpr and Bcl2l11+/Faslpr/lpr
mice compared to WT mice or animals lacking only one of these
apoptosis inducers (Figure 4). This shows that the Fas-activated
culture with the apoptotic stimuli indicated and survival assessed daily by
propidium iodide staining and FACS analysis.
(B and C) Similar experiments were performed with CD4+CD8 and
CD4CD8+ T cells (B) and abTCR+CD4CD8B220+ T cells (C) purified from
lymph nodes of mice of the genotypes indicated. Data represent the mean ±
SEM of 3–7 mice for each genotype.
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Bim and Fas Cooperate in Chronic Immune Responsesdeath receptor and the Bim-mediated mitochondrial apoptotic
pathways act synergistically to control homeostasis of all mature
lymphocyte subpopulations and granulocyte turnover.
The thymi of Bcl2l11/Faslpr/lpr, Bcl2l11+/Faslpr/lpr, Bcl2l11/,
Faslpr/lpr, and WT mice were all similar in size and cellularity. The
distribution of the four major cellular subsets (defined by the
expression of CD4 and CD8) within the thymus of Bcl2l11/
Faslpr/lprmicewas comparable to that ofBcl2l11/mice (Bouillet
et al., 1999), with a reduction in CD4+CD8+ cells and a 2- to 3-fold
increase in CD4CD8 as well as mature (CD4+CD8 and
CD4CD8+) T cells (Figure S4). Thus, loss of Bim and Fas
do not cooperate to cause abnormalities in the thymus, demon-
strating that the enhanced lymphadenopathy and spleno-
megaly seen in Bcl2l11/Faslpr/lpr and Bcl2l11+/Faslpr/lpr
mice are a consequence of defects in peripheral lymphoid
organs.
Lymphadenopathy in Bcl2l11/Faslpr/lpr
and Bcl2l11+/Faslpr/lpr Mice Is Not Associated
with Lymphoid Malignancy
Deregulation of apoptosis is thought to contribute to the devel-
opment of many, perhaps all, types of cancer (Hanahan and
Figure 2. AccumulationofLeukocytes, TotalCD8+TCells,
and HSV-1-Specific CD8+ T Cells in Bcl2l11/Faslpr/lpr,
Bcl2l11/, Faslpr/lpr, or WT Mice after HSV-1 Infection
(A–D) Total numbers of leukocytes (A, C) and total numbers of
CD8+ T cells (B, D) from spleen and popliteal lymph nodes of
HSV-1-infectedmice were quantified by cell counting and staining
with CD8 mAbs followed by FACS analysis. Data from spleens
represent the mean ± SEM from 3–4 mice of each genotype (2
for Bcl2l11+/Faslpr/lpr). Lymph node samples from mice of the
same genotype (3–4 mice of each genotype except 2 for
Bcl2l11+/Faslpr/lpr) were pooled and analyzed together 17 and
35 days after infection.
(E and F) Mice of the indicated genotypes were injected subcuta-
neously with HSV-1 in each hindfoot, and HSV-specific CD8+ T
cells in spleen (E) and popliteal lymph nodes (F) were enumerated
after 17 and 35 days by immunofluorescent staining with anti-
bodies to CD8 plus PE-streptavidin-conjugated Kb tetramers
loaded with the immunodominant HSV-1 epitope followed by
FACS analysis. Lymph node samples from mice of the same
genotype were pooled. Data points represent the mean ± SEM
of 3–4 mice (2 for Bcl2l11+/Faslpr/lpr).
Weinberg, 2000). We have previously shown that loss
of Bimaccelerates lymphomadevelopment inmice ex-
pressing a Myc transgene in their B cell compartment
(Egle et al., 2004). Because the dramatic expansion of
the lymphocyte compartment in Bcl2l11/Faslpr/lpr
and even the Bcl2l11+/Faslpr/lpr mice was due to the
disruption of apoptotic pathways, we examined
whether the T cells accumulating in these animals
were monoclonal and hence most likely lymphoma-
tous. However, immunofluorescent staining with
a panel of monoclonal antibodies to different TCR-Vb
subtypes demonstrated that T cells from multiple
lymph nodes of different Bcl2l11/Faslpr/lpr mice had
a normal polyclonal repertoire of TCR specificities (Fig-
ure 5; Figure S7). To confirm the absence of hemato-
logical (or other) malignancy in Bcl2l11/Faslpr/lpr mice, we ver-
ified that C57BL/6 mice injected with 2 3 106 lymph node cells
from several Bcl2l11/Faslpr/lpranimals did not develop tumors
over a 12 month observation period (data not shown). These re-
sults show that theextreme lymphadenopathy andsplenomegaly
inBcl2l11/Faslpr/lpr andBcl2l11+/Faslpr/lprmice are caused by
the polyclonal expansion of nontransformed lymphocytes.
Autoimmune Pathology in Bcl2l11/Faslpr/lpr
and Bcl2l11+/Faslpr/lpr Mice
Bim (Davey et al., 2002) as well as Fas (Van Parijs et al., 1998)
have been implicated in the killing of T cells chronically activated
by self-antigens, so it appears predictable that loss of both may
synergize to cause severe immunopathology. Although Faslpr/lpr
(Watanabe-Fukunaga et al., 1992) as well as Bcl2l11/ (Bouillet
et al., 1999) mice generally produce autoantibodies, they de-
velop immune-complex deposits and fatal SLE-like autoimmune
disease only on particular genetic backgrounds (e.g., MRL for lpr
mice or mixed C57BL/6x129SV for Bcl2l11/ mice). On the
C57BL/6 background,Bcl2l11/mice develop lymphocyte infil-
trates in lung, liver, and kidneys around 1 year of age, but these
have no discernible consequences for their health. All Faslpr/lpr
200 Immunity 28, 197–205, February 2008 ª2008 Elsevier Inc.
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healthy, and histological examination did not show any signs of
severe autoimmunity. In contrast, all Bcl2l11/Faslpr/lpr and
even the Bcl2l11+/Faslpr/lpr mice had become moribund by
250 days of age, with a median survival of 114.5 days for
Bcl2l11/Faslpr/lpr mice and 159 days for Bcl2l11+/Faslpr/lpr
mice (Figure 6). Almost all of these animals had to be sacrificed
because they presented with labored breathing resulting from
filling of the chest cavity by large lymph nodes. Histological
examination revealed the presence of massive lymphocyte infil-
trates in the lungs, kidneys, and liver of Bcl2l11/Faslpr/lpr and
Bcl2l11+/Faslpr/lpr mice (Figure 6A). All moribund mice also
tested positive for the presence of anti-DNA autoantibodies
(not shown). 20%–30% of the Bcl2l11/Faslpr/lpr and 10% of
the Bcl2l11+/Faslpr/lpr mice also presented with urticarial rash
between the ears and in the neck area. In contrast, all Faslpr/lpr,
Bcl2l11/, and WT mice survived well beyond 250 days without
symptoms.Theseobservationsdemonstrate thatBim-dependent
mitochondrial apoptosis and Fas death receptor signaling co-
operate in hematopoietic cell homeostasis and prevention of im-
munopathology.
Figure 3. After Intranasal MHV-OVA Infection, Bcl2l11/Faslpr/lpr
Mice Accumulate More Viral Antigen-Specific CD8+ T Cells than
Bcl2l11/, Faslpr/lpr, or WT Mice
Mice were infected intranasally with MHV-OVA and sacrificed after 14, 40, or
60 days, and mediastinal lymph nodes and spleen were analyzed.
(A–D) Total leukocytes (A, B) and total numbers of CD8+ T cells (C, D) from
spleen and mediastinal lymph nodes were quantified by cell counting and
staining with CD8 mAbs followed by FACS analysis. Data represent the
mean ± SEM from 3–4 mice of each genotype. Lack of data at day 14 for
the Bcl2l11+/Faslpr/lpr genotype is indicated with an asterisk.
(E–H) MHV-OVA-specific CD8+ T cells were measured by immunofluorescent
staining with PE-streptavidin-conjugated Kb/SIINFEKL tetramers plus anti-
bodies to CD8 (E, F), or, after brief antigenic stimulation in vitro, by intracellular
staining for IFN-g (G, H), both followed by FACS analysis. Lymph node
samples from mice of the same genotype were pooled. Data points represent
themean ± SEMof 3–4mice (2mice at some time points forBcl2l11+/Faslpr/lpr
and Faslpr/lpr mice).
Figure 4. Loss of Bim and Fas Synergize in the Development of
Lymphadenopathy and Splenomegaly
Mice (WT, Bcl2l11/, Faslpr/lpr, Bcl2l11+/Faslpr/lpr, and Bcl2l11/Faslpr/lpr)
were analyzed between the ages of 6 and 10 weeks. Spleen and lymph
node cells were counted and analyzed by immunofluorescent staining with
surface marker-specific antibodies and FACS analysis. Data represent
mean ± SEM from 3–6 mice of each genotype.
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Immune responses to an infectious pathogen or injection of a for-
eign substance result in the clonal expansion of antigen-specific
T cells and, upon pathogen or antigen clearance, this is followed
by contraction of this T cell population (Sprent and Tough, 2001).
The shutdown of T cell immune responses is mediated by their
programmed death (Kawabe and Ochi, 1991), but the mecha-
nisms for apoptosis induction remain controversial (Hildeman
et al., 2002; Krammer, 2000). This is (at least in part) due to the
use of different model systems. Culturing antigen- or mitogen-
activated T cells with IL-2 and restimulating them through the
TCR or with PMAplus ionomycin has long been used as the stan-
dard in vitro model to mimic the removal of activated T cells
in vivo (Krammer, 2000). Experiments with blocking antibodies
or FasL- or Fas-deficient mutant mice demonstrated that in
this setting, TCR restimulation causes the expression of FasL,
which induces autocrine and/or paracrine killing of Fas-express-
ing T cells (Brunner et al., 1995; Dhein et al., 1995; Russell et al.,
1993). This led to the conclusion that FasL-Fas signaling is re-
sponsible for the shutdown of T cell immune responses. Some
studies showed that deletion of SEB-activated T cells in mice
was in part FasL-Fas dependent (Mogil et al., 1995; Renno
et al., 1996), whereas others found that Fas deficiency (in
Faslpr/lpr mutant mice) had no impact but that loss of Bim pro-
vided profound protection (Hildeman et al., 2002). These
discrepancies might be due to differences in the regimes of
SEB injection. This is supported by the finding that effects of
Fas deficiency on deletion of activated T cells in vivo were ob-
served most consistently when mice were administered several
doses of SEB (Strasser et al., 1995). Interestingly, the death of
antigen-activated CD8+ T cells during shutdown of and acute
immune response to a viral (HSV-1) infection was substantially
inhibited by loss of Bim but was not affected by Fas deficiency
(Pellegrini et al., 2003). We therefore reasoned that depending
on the nature of an immune response—acute versus chronic—
Fas-mediated death receptor signaling and Bim-dependent
mitochondrial apoptosis might contribute to different extents to
the killing of activated T cells (Strasser and Pellegrini, 2004). Ac-
cordingly, a single low-dose challenge with SEB would mimic
a response to an acute infection, whereas high-dose and/or
repeated challenge with this superantigen would be expected
to resemble the response to a chronic infection.
Figure 5. Bcl2l11/Faslpr/lpr Mice Have a Normal Polyclonal Usage
of TCR-Vb Chains in Lymph Node T Cells
TCR-Vb chain expression on lymph node T cells from Bcl2l11/Faslpr/lpr and
WT mice was analyzed by FACS after staining with mAbs to Thy-1 plus mAbs
to Vb3, Vb4, Vb5, Vb6, Vb7, Vb8, or Vb10. The percentages of T cells express-
ing each TCR-Vb chain and the mean are represented.
202 Immunity 28, 197–205, February 2008 ª2008 Elsevier Inc.Our analysis of Bcl2l11/Faslpr/lprmice demonstrates that kill-
ing of activated T cells during termination of a response to acute
infection relies predominantly on Bim with no apparent contribu-
tion by Fas death receptor signaling. In contrast, these two path-
ways synergize in the killing of T cells during shutdown of an
immune response to chronic infection, and they also cooperate
tomaintainhomeostasisofTcells,Bcells, aswell asgranulocytes,
and to prevent autoimmune pathology. These results help recon-
cile current controversies regarding the relative contributions of
the death receptor versus the mitochondrial apoptotic pathway
to the shutdown of T cell immune responses. They are consistent
with the notion that during shutdown of an acute immune re-
sponse, killing of activated T cells is not elicited by repeated
TCR ligation, which would have been required for activation of
the Fas pathway (Hildeman et al., 2002; Pellegrini et al., 2003). In-
stead, apoptosis requires the BH3-only protein Bim, which is
thought to be activated by the drop in cytokine levels that occurs
after pathogen clearance (Strasser and Pellegrini, 2004). This fits
with the observations that Bim is critical for cytokine depriva-
tion-induced apoptosis (Bouillet et al., 1999) and transcriptionally
(Dijkers et al., 2000) aswell aspost-translationally (reviewed in Ley
et al., 2005) activated by this death stimulus. It is possible that
a drop in the levels of prosurvival Bcl-2 family members, particu-
larly Bcl-2 (Hildeman et al., 2002), and/or the induction of the
BH3-only protein Puma (encoded by the Bbc3 gene), which is
also involved in growth factor withdrawal-induced apoptosis of
hemopoietic cells (Jeffers et al., 2003; Villunger et al., 2003), are
also involved in the killing of antigen-activated T cells during shut-
down of an acute immune response. Indeed, Bim and Puma dou-
bly deficient T cells survive better in culture in the absence of cy-
tokines than those lackingonlyBimorPuma (Erlacher et al., 2006).
Analysis of HSV-1-infected Bcl2l11/Puma/ mice could help
determinewhether these twoBH3-only proteins have overlapping
functions in the shutdown of acute T cell immune responses.
The finding that Fas-mediated death receptor signaling and the
Bim-dependent mitochondrial apoptosis both contribute to shut-
down of chronic immune responses is consistent with the obser-
vations that loss of Bim (Grayson et al., 2006), Bcl-2 overexpres-
sion (Strasser et al., 1995), or loss of Fas (Kawabe and Ochi,
1991), each on their own, enhanced (to a relatively small extent)
survival of T cells chronically stimulated by repeatedSEB injection
orLCMV infection.These results areconsistentwith thenotion that
the death receptor and the mitochondrial apoptotic pathways are
distinct and that they can cooperate in the removal of a cell popu-
lation (Strasser et al., 1995). Our results are reminiscent of the
effects observed upon the overexpression of Bcl-2 in Faslpr/lpr
mice. It is highly probable that Bcl-2 might have countered Bim
function in thesemice. The importance of the genetic background
on the severity of the Faslpr/lpr and Bcl2l11/ phenotypes is well
established. Direct comparison of the Bcl2-tg Faslpr/lpr mice and
our present study is limitedby the fact that themiceused in the for-
mer study were on the C3H/HeJ background, whereas the
Bcl2l11/Faslpr/lpr mice are on the C57BL/6 background. It is,
however, possible that other BH3-only proteins may be involved
in the killing of chronically activated T cells, and lymphadenopathy
and splenomegaly may therefore be even more severe in Bcl2-tg
Faslpr/lpr mice than in Bcl2l11/Faslpr/lpr mice.
It appears likely that repeated TCR stimulation causes activa-
tion of the FasL-Fas signaling pathway in T cells during chronic
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Bim and Fas Cooperate in Chronic Immune Responsesinfection (Brunner et al., 1995; Dhein et al., 1995), but how Bim is
induced in this setting is less clear. This might be a consequence
of a drop in the amounts of cytokines, similar to shutdown of
acute immune responses. Alternatively, the calcium flux elicited
by repeated TCR ligation might activate Bim (Bouillet et al.,
Figure 6. Accelerated Immunopathology and Premature Death
in Bcl2l11/Faslpr/lpr and Bcl2l11+/Faslpr/lpr Mice
(A) Lungs (i, iv), kidney (ii, v), and liver (iii, vi) of a 260-day-old Bcl2l11+/+Faslpr/lpr
mouse (i, ii, iii) and a 114-day-old Bcl2l11/Faslpr/lpr mouse (iv, v, vi) showing
large lymphocyte infiltrates inBcl2l11/Faslpr/lpr tissues. Scale bars represent
1 mm.
(B) Bcl2l11/Faslpr/lpr (n = 8) and Bcl2l11+/Faslpr/lpr (n = 10) mice were found
dead in their cages at the indicated times. No Bcl2l11+/+Faslpr/lpr, Bcl2l11/
or WT mice (n = 10) were found dead by 250 days. p < 0.001 for both
Bcl2l11+/Faslpr/lpr and Bcl2l11/Faslpr/lpr mice.
(C) Model for induction of apoptosis in T lymphocytes during shutdown of an
acute or chronic immune response. Single stimulation of the TCR in an acute
response triggers activated T cell death via Bim, whereas repeated stimulation
in a chronic infection recruits Fas to contract the activated T cell population.2002), and, pertinently, Bim is essential for deregulated calcium
flux-induced apoptosis (Bouillet et al., 1999).
Combined loss of Fas and Bim also synergized in causing
lymphadenopathy, demonstrating that these two pathways co-
operate not only in the killing of T cells chronically activated by
pathogen-borne antigens but also those stimulated by self-anti-
gens. The unusual abTCR+CD4CD8B220+ T lymphoid cells
are seen only in Faslpr/lpr but not in Bcl2l11/ mice, consistent
with the view that they are descendants of chronically activated
‘‘conventional’’ T cells, which previously expressed CD4 or CD8
(Renno et al., 1996) and would normally be killed by FasL-Fas
signaling (Brunner et al., 1995; Dhein et al., 1995). These unusual
T cells are as sensitive as conventional T cells to cytokine depri-
vation but can be protected by loss of Bim, providing a likely ex-
planation as to why their numbers are greatly increased in
Bcl2l11/Faslpr/lpr and even Bcl2l11+/Faslpr/lpr mice compared
to animals lacking only Fas. Although loss of either Fas or Bim
causes fatal autoimmune disease on certain genetic back-
grounds (e.g., MRL for Faslpr/lpr [Watanabe-Fukunaga et al.,
1992] or mixed C57BL/6x129SV for Bcl2l11/ [Bouillet et al.,
1999]), such pathology is not apparent for either mutation
on an inbred C57BL/6 background. The immunopathology
seen in Bcl2l11/Faslpr/lpr and Bcl2l11+/Faslpr/lpr mice on this
background therefore demonstrates that these two apoptotic
pathways have overlapping functions in the prevention of
autoimmune disease.
These findings have implications for clinical medicine. For ex-
ample, abnormally increased levels ofBimand enhancedsensitiv-
ity toFasL (Gougeon,2003)havebeendetected in leukocytes from
patients infected with human immunodeficiency virus (HIV) or
other pathogens. Thus, Bim- and Fas-mediated apoptosis may
cooperate to cause the excessive killing of antigen-specific T cells
that is thought to impair clearance of the infectious microbes in
these settings.Conversely, the inability tokill T cells that arechron-
ically stimulated by self-antigens might underlie some autoim-
mune conditions. For example, because loss of one allele of Bim
synergizes with Fas deficiency to cause immunopathology, it is
possible that combinationsofmutantalleles ofBimandFas,which
by themselvesdonot cause readily identifiable abnormalities,may
underlie certain autoimmune diseases in humans.
In summary, two major pathways regulate the life and death of
lymphocytes. The death receptor pathway involves membrane
receptors of the TNFR1 family, whereas the mitochondrial path-
way is regulated by proteins of the Bcl-2 family. Here, we show
that both pathways synergize to kill activated T cells in chronic
immune responses, whereas death of activated T cells in acute
immune responses relies only on the mitochondrial pathway.
EXPERIMENTAL PROCEDURES
Mice
All animal experimentswere performed in accordancewith the guidelines of the
Melbourne Directorate Animal Ethics Committee.Bcl2l11/ and Faslpr/lprmice
had been backcrossed onto a C57BL/6 genetic background for >20 genera-
tions prior to intercrossing and were housed in specific pathogen-free (SPF)
conditions prior to infectious challenge.
Immunofluorescent Staining, FACS Analysis, Cell Sorting, Tissue
Culture, and Cell-Survival Assays
Single-cell suspensions were prepared from thymus, spleen, and lymph nodes
(axillary, brachial, and inguinal) of 6- to 10-week-old mice and total leukocyte
Immunity 28, 197–205, February 2008 ª2008 Elsevier Inc. 203
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rescent staining with surface marker-specific mAbs coupled to FITC, R-PE,
APC, Cy5, or biotin (the latter revealed by staining with streptavidin coupled
to R-PE or Tricolor; Caltag) followed by flow cytometric analysis in a FACScan
(Becton Dickinson) or sorting in a FACSDIVA (Becton Dickinson) or MoFlo (Cy-
tomation). Sorted cells were resuspended in DMEM supplemented with 10%
FCS, 50 mM 2-mercaptoethanol (2-ME), and 100 mM asparagine and cultured
at 37C in 96-well flat-bottom plates. Cells were incubated in medium alone
(no treatment, i.e., cytokine deprivation) or treated with FLAG-tagged human
recombinant FasL 10 ng/mL (Alexis) crosslinkedwith 1 mg/mLM2 FLAGmono-
clonal antibody (Sigma), ionomycin (1 mg/mL), PMA (10 ng/mL), etoposide
1 mg/mL, or g-irradiated (1.25 Gy). Cell survival was quantified daily by staining
with propidium iodide (PI; 2 mg/mL) and FACS analysis.
HSV Infection and Quantification of HSV Antigen-Specific
CD8+ T Cells
Mice were injected subcutaneously (s.c.) in each hind foot with 43 105 plaque-
forming units (PFU) of HSV-1 KOS strain under general anesthesia. After 17
and 35 days, mice were killed, and popliteal lymph nodes, spleen, liver, lungs,
and feet were removed. Single-cell suspensions were prepared from these tis-
sues, and those from the lymph nodes of mice of the same genotypes were
pooled. Lymphocytes were purified from liver and lung on Percoll density gra-
dients. To measure the percentages of viral antigen-specific T cells, single-cell
suspensions from spleen and lymph nodes were first enriched for CD8+ T cells
with magnetic bead depletion by staining with M1/70 (anti-Mac-1), F4/80
(macrophage marker), Ter 119 (erythroid marker), RB6-8C5 (anti-Gr-1),
M5/114 (anti-class II MHC), and GK 1.5 (anti-CD4) antibodies followed by
incubation with goat anti-rat IgG antibody-coupled magnetic beads (Dynal,
Oslo and QIAGEN). Enriched CD8+ cells were washed and stained for 45
min at room temperature with PE-streptavidin-conjugated Kb-gB tetramers
containing the immuno-dominant HSV gB498-505 peptide. Cells were then
stained for 30 min on ice with APC-conjugated CD8 mAb (53-6.7) in balanced
salt solution containing 2% FBS. PI staining was used to exclude dead cells
and data were acquired on at least 104 viable cells with a FACSCalibre flow
cytometer and analyzed with CellQuest Pro (BD Biosciences).
MHV Infection and Quantification of Viral Antigen-Specific
CD8+ T Cells by Staining with PE-Streptavidin-Conjugated
Kb-OVA Tetramers
Mice were infected under brief general anesthesia intranasally with 3 3 104
PFU of recombinant murine g-herpesvirus that coexpressed ovalbumin
(OVA) from an intergenic expression cassette driven by an ectopic MHV-68
lytic promoter (MHV 68-OVA). Infected mice were killed after 14, 40, or 60
days, and lungs, mediastinal lymph nodes, and spleen were collected. Sin-
gle-cell suspensions were prepared and leukocytes within the lymph nodes
and spleen were counted. Cells collected from the lymph nodes from mice
of the same genotype were pooled. Total numbers of CD4+ and CD8+ T cells
were measured by staining cells for 30 min on ice with PE-coupled anti-CD4
mAb (CT-CD4) and FITC-coupled anti-CD8 mAb (CT-CD8), and analysis was
performed as described above. To enumerate viral antigen-specific T cells,
suspensions from lymph nodes and spleen were enriched for CD8+ T cells
as described above, labeled for 30 min on ice with FITC-coupled anti-CD8
mAb, washed, stained for 45 min at RT with PE-coupled streptavidin conju-
gated to Kb class I MHC tetramers loaded with SIINFEKL peptide, and then
analyzed as described above.
Intracellular FACS Analysis of Cytokine Production
Approximately 13 106 cells from lymph nodes or spleen ofBcl2l11/Faslpr/lpr,
Bcl2l11+/Faslpr/lpr, Faslpr/lpr, Bcl2l11/, and WT mice were incubated for 5 hr
at 37C in RPMI 1640 supplementedwith 50 mM2-ME, 10%FBS, 5 mg/mL bre-
feldin A (which was also provided in all subsequent washes and incubations),
and 10 U/mL recombinant mouse IL-2 plus either 1 mM HSV gB498-505 pep-
tide for mice infected with HSV or 1 mMOvalbumin257-265 (SIINFEKL) peptide
for mice infected with MHV-OVA or, as a control, with no peptide. Cells were
harvested, washed, stained for 30 min on ice with FITC-coupled anti-CD8
mAb, washed again, fixed for 15 min at 4C with 1% formalin, permeabilized
for 10 min at RT in PBS containing 0.5% saponin and 1% BSA, stained for
30 min on ice with PE-coupled rat anti-IFN-g mAb (C1 XMG1.2), washed,
204 Immunity 28, 197–205, February 2008 ª2008 Elsevier Inc.and analyzed on a LSR or FACSCalibre flow cytometer. The frequency of
virus-specific CD8+ T cells was calculated by subtracting the frequency of
CD8+ IFN-g+ T cells in samples stimulated with no peptide from the frequency
of CD8+ IFN-g+ T cells in samples with the antigenic peptide.
MHV-OVA Viral Titer Assays
Titers of infectious MHV-OVA virus were determined by plaque assay. In brief,
10-fold dilutions of (virus containing) spleen cell suspensions from infected
mice were incubated for 2 hr on BHK-21 cell monolayers. The inoculum was
then removed and the monolayers overlaid with Dulbecco’s modified Eagle
medium containing 0.3% carboxymethylcellulose. After 5 days, the mono-
layers were fixed in 10% formaldehyde and stained with 10% Giemsa (Merck)
for 30 min before rinsing with water. Monolayers were dried at room tempera-
ture overnight before plaques were counted with a plate microscope.
Analysis of Persisting Antigen Presentation
during MHV-OVA Infection
Persistent antigen presentation was evaluated by analyzing the induction of
proliferation of CFSE-labeled OVA-specific CD8+ T cells (from OT-I TCR trans-
genic mice) after injection into mice that had been infected with MHV-OVA for
various lengths of time. In brief, lymphocyte suspension from lymph nodes (in-
guinal, axillary, sacral, cervical, and mesenteric) of OT-I TCR transgenic mice
were enriched for CD8+ T cells by incubationwith antibodies specific forMac-1
(M1/70), Mac-3 (F4/80), erythrocytes (Ter-119), B220 (RA3-6B2), MHC class II
(M5/114), and CD4 (GK1.5). Antibody-coated cells were removed with goat
anti-rat IgG antibody-coated magnetic beads (QIAGEN). Purity was verified
by FACS analysis and was routinely found to be 95%. Enriched CD8+ T
cell preparations were resuspended at 107 cells/mL in PBS containing 0.1%
BSA and incubated for 10 min at 37C with 5 mM CFSE stock solution (5 mM
in DMSO, Molecular Probes). 1 3 106 CFSE-labeled OT-I TCR transgenic T
cells were injected into naive or MHV-OVA-infected mice, and proliferation
was analyzed by FACS analysis after 3 days to determine the reduction in
CFSE staining intensity.
TCR-Vb Expression Analysis
TCR-Vb expression was analyzed by preparing cell suspensions from multiple
separate lymph nodes from Bcl2l11/Faslpr/lpr with massive lymphadenopa-
thy (aged approximately 12 weeks). Cells were stained with FITC-coupled
Thy-1 mAb (T24.31.2) and biotinylated mAbs specific for TCR Vb3, 4, 5, 6, 7,
8, or 10 (BD PharMingen), followed by R-phycoerythrin (PE)-streptavidin. PI
was used to exclude dead cells and cells were analyzed in a FACScan.
Supplemental Data
Seven figures are available at http://www.immunity.com/cgi/content/full/28/2/
197/DC1/.
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